Suboxone Creator’s Shocking Scheme to Profit Off of Heroin Addicts
The company behind America’s most popular drug to treat addicts actually claimed its pills could kill kids to get a new patent and $1 billion.
Reckitt Benckiser’s patent for its opiate-treatment drug Suboxone expired, opening the gates for cheaper generic versions of the medication to hit the market. At stake was the loss of the company’s 85 percent hold on the market for medication-assisted treatment, which was booming thanks to the growing opiate epidemic. Hundreds of millions stood to be lost from the patent’s expiration.